Back to companies

Arcus Biosciences Inc: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

Arcus Biosciences Inc (Arcus Biosciences) is a clinical-stage biopharmaceutical company focused on creating innovative cancer immunotherapies by leveraging underexploited biological opportunities. Its product pipeline includes Casdatifan (CAS) treats kidney cancer; Domvanalimab (DOM) targets gastrointestinal cancer and lung cancer; Quemliclustat (QUEMLI) for pancreatic cancer and lung cancer; Etrumadenant (ETRUMA) which targets colorectal cancer; AB598 for gastrointestinal cancer; and AB801 which treats lung cancer. The company operates it offices in Brisban and Hayward, California, the US. Arcus Biosciences is headquartered in Hayward, California, the US.

 Gain a 360-degree view of Arcus Biosciences Inc and make more informed decisions for your business Gain a 360-degree view of Arcus Biosciences Inc and make more informed decisions for your business Register your interest
Headquarters United States of America
Address 3928 Point Eden Way, Hayward, California, 94545
Website arcusbio.com
Telephone 1 510 6946200
No of Employees 601
Industry Pharmaceuticals and Healthcare
Ticker Symbol & Exchange RCUS (NYSE)
Revenue (2024) $247.0M -4.3% (2024 vs 2023)
EPS XYZ
Net Income (2024) XYZ -24.7% (2024 vs 2023)
Market Cap* $3.6B
Net Profit Margin (2024) XYZ -30.3% (2024 vs 2023)
* As of and is in US$
View Arcus Biosciences Inc financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Register your interest

Arcus Biosciences Inc premium industry data and analytics

120+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Arcus Biosciences Inc’s relevant decision makers and contact details.

100+

Catalyst Calendar

Proactively evaluate Arcus Biosciences Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

50+

Clinical Trials

Determine Arcus Biosciences Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

20+

Pipeline Drugs

Identify which of Arcus Biosciences Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

4

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

3

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

Products and Services

Products
Pipeline
Casdatifan (CAS): Kidney Cancer
Domvanalimab (DOM): Gastrointestinal Cancer and Lung Cancer
XYZ
XYZ
XYZ
Understand Arcus Biosciences Inc portfolio and identify potential areas for collaboration Understand Arcus Biosciences Inc portfolio and identify potential areas for collaboration Register your interest
Image for loader

Competitor Comparison

Key Parameters Arcus Biosciences Inc Merck & Co Inc Pfizer Inc AstraZeneca Plc Novartis AG
Headquarters United States of America United States of America United States of America United Kingdom Switzerland
City Hayward Rahway New York City Cambridge Basel
State/Province California New Jersey New York Cambridgeshire Basel-Stadt
No. of Employees 601 75,000 75,000 96,100 75,267
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Register your interest
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Register your interest
Executives
Name Position Board Since Age
Terry Rosen, Ph.D Chief Executive Officer; Chairman Executive Board 2017 66
Robert C. Goeltz Chief Financial Officer Senior Management 2020 53
Jennifer Jarrett Chief Operating Officer Senior Management 2020 55
Alex Azoy Chief Accounting Officer Senior Management - -
Richard Markus, MD, PhD Chief Medical Officer Senior Management 2025 60
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into Arcus Biosciences Inc key executives to enhance your sales strategy Gain insight into Arcus Biosciences Inc key executives to enhance your sales strategy Register your interest
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?